Acute Coronary Syndromes – A Handbook for Clinical Practice
Wiley-Blackwell (an imprint of John Wiley & Sons Ltd) (Hersteller)
978-1-4443-1285-0 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
The management of non-ST segment elevation acute coronary syndromes (NSTE-ACS) has rapidly evolved over the last few years and many guidelines have been provided and already updated. This book is based on the latest ESC Guidelines and reports the current knowledge in NSTE-ACS, together with the most recent therapeutic options and the different strategies that can be applied according to the clinical status of patients. International experts address the different aspects of NSTE-ACS and bring useful information to clinicians, interventionalists and surgeons involved in the difficult management of these patients. The ESC Education Series This book is part of the ESC Education Series. The series is designed to provide medical professionals with the latest information about the understanding, diagnosis and management of cardiovascular diseases. Where available, management recommendations are based on the established European Guidelines, which encompass the best techniques to use with each cardiac disease. Throughout the series, the leading international opinion leaders have been chosen to edit and contribute to the books.
The information is presented in a succinct and accessible format with a clinical focus.
Michael Bertrand, Emeritus Professor of Cardiology, Lille Heart Institute, Lille, France Dr Spencer King III, Fuqua Chair of Interventional Cardiolo, Fuqua institute, Atlanta, GA, USA
List of contributors. Preface. Section one: Epidemiology . 1 Epidemiology of non-ST-segment elevation acute coronary syndromes. David Hasdai and Alexander Battler . Section two: Pathophysiology . 2 Pathologic findings in acute coronary syndromes . Erling Falk . 3 Vascular biology of acute coronary syndromes . Lina Badimon . Section three: Clinical aspects of ACS . 4 Clinical aspects of acute coronary syndromes . Eugene McFadden . 5 Circulating biomarkers for risk stratification . Christopher Heeschen . Section four: Investigation in ACS . 6 Coronary angiography, angioscopy, and intravascular ultrasound in non-ST segment elevation acute coronary syndromes . Eric Van Belle, Christophe Bauters, Francois Schiele, and Michel E. Bertrand . 7 New coronary imaging in acute coronary syndrome . Pim J. de Feyter, Evelyne Regar, and Nico R.A. Mollet . Section five: Special groups of patients . 8 Acute coronary syndromes in special groups of patients . Piero O. Bonetti, Michael J. Zellweger, Christoph Kaiser, and Matthias E. Pfisterer . Section six: Pharmacological treatment . 9 Antiischemic treatment (nitrates, beta -blockers, calcium antagonists) . David McCarty, Colum G. Owens, and A.A. Jennifer Adgey . 10 Antiplatelet therapies: aspirin, thienopyridines, and glycoprotein IIb/IIIa receptor inhibitors . Jaydeep Sarma and Keith A.A. Fox . 11 Antithrombin drugs: LMWH, unfractionated heparin, direct thrombin inhibitors . Raphaelle Dumaine and Gilles Montalescot . 12 Statin therapy in ACS . Francois Schiele . Section seven: Myocardial revascularization . 13 Percutaneouscoronary interventionsand stenting/CABG in non-ST-segment elevation acute coronary syndromes . Nicolas Meneveau and Jean-Pierre Bassand . Section eight: Therapeutic strategy . 14 Risk stratification and therapeutic strategy . Christian W. Hamm . 15 Indication for revascularization in non-ST-elevation acute coronary syndrome . Lars Wallentin . 16 Management of patientswith nonamenable lesions for myocardial revascularization . Victor Legrand . 17 Non-ST-segment elevation coronary syndromes: European Society of Cardiology guidelines . Michel E. Bertrand . 18 Non-ST-segment elevation acute coronary syndromes: ACC/AHA guidelines . Pierre Theroux . 19 From guidelines to registries . Luigi Tavazzi . Section nine: Secondary prevention . 20 Secondary prevention after acute episode of patients presenting with nonpersistent ST-segment elevation . Michel E. Bertrand . 21 How to detect vulnerable plaque . Dirk Boese and Raimund Erbel . 22 Local versus systemic prevention treatment . Mario Togni and Bernhard Meier. Conclusions. Index
| Erscheint lt. Verlag | 5.5.2009 |
|---|---|
| Verlagsort | Chicester |
| Sprache | englisch |
| Maße | 169 x 242 mm |
| Gewicht | 736 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete |
| ISBN-10 | 1-4443-1285-5 / 1444312855 |
| ISBN-13 | 978-1-4443-1285-0 / 9781444312850 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
